Philip N. Patsalos
Institute of Neurology/The National Hospital for Neurology and Neurosurgery
London and The Chalfont Centre for Epilepsy
Chalfont St Peter
United Kingdom
Name/email consistency: high
- Antiepileptic drugs--best practice guidelines for therapeutic drug monitoring: a position paper by the subcommission on therapeutic drug monitoring, ILAE Commission on Therapeutic Strategies. Patsalos, P.N., Berry, D.J., Bourgeois, B.F., Cloyd, J.C., Glauser, T.A., Johannessen, S.I., Leppik, I.E., Tomson, T., Perucca, E. Epilepsia (2008)
- In situ metabolism of levetiracetam in blood of patients with epilepsy. Patsalos, P.N., Ghattaura, S., Ratnaraj, N., Sander, J.W. Epilepsia (2006)
- Properties of antiepileptic drugs in the treatment of idiopathic generalized epilepsies. Patsalos, P.N. Epilepsia (2005)
- Clinical pharmacokinetics of levetiracetam. Patsalos, P.N. Clin. Pharmacokinet (2004)
- The pharmacokinetic characteristics of levetiracetam. Patsalos, P.N. Methods. Find. Exp. Clin. Pharmacol (2003)
- Clinically important drug interactions in epilepsy: general features and interactions between antiepileptic drugs. Patsalos, P.N., Perucca, E. Lancet. Neurol (2003)
- Clinically important drug interactions in epilepsy: interactions between antiepileptic drugs and other drugs. Patsalos, P.N., Perucca, E. Lancet. Neurol (2003)
- The importance of drug interactions in epilepsy therapy. Patsalos, P.N., Fröscher, W., Pisani, F., van Rijn, C.M. Epilepsia (2002)
- Pharmacokinetic profile of levetiracetam: toward ideal characteristics. Patsalos, P.N. Pharmacol. Ther. (2000)
- Anti-epileptic drugs: newly licensed and under development. Patsalos, P.N. IDrugs (2000)